Catheter-based therapy for congenital heart disease (percutaneous closure, cardiac catheterization); early diagnosis and cardiovascular-complication management of Kawasaki disease; pharmacologic; cardiomyopathy work-up and care; advanced non-invasive assessment with echocardiography, cardiac MRI, and electrocardiography.

Genetic susceptibility to congenital heart defects; risk-stratification biomarkers for coronary artery lesions in Kawasaki disease; macrophage-activation syndrome within Kawasaki disease; acute cardiogenic liver injury in adolescent heart failure; clinical validation of red-cell-distribution width as a predictive marker for coronary involvement..